These final results, together with a prior report demonstrating that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 support the principle of focusing on ACKR3 as a singular method to modulate the opioid system, which could open new therapeutic avenues for opioid-similar disorders. These outcomes propose that https://jamesp495ckf8.sasugawiki.com/user